Cortex Pharmaceuticals Inc Headquarters
Looking for information about Cortex Pharmaceuticals Inc Headquarters? The links below have collected all the necessary data.
https://craft.co/respirerx-phamaceuticals
Jun 08, 2021 · RespireRx Pharmaceuticals Inc. (formerly Cortex Pharmaceuticals, Inc.) is focused on developing drug candidates to treat very large respiration related markets that are unserved or poorly served. RespireRx is also developing drugs for niche respiratory markets …
https://www.crunchbase.com/organization/cortex-pharmaceuticals
Phone Number (917) 834-7206. RespireRx Pharmaceuticals Inc. is focused on developing drug candidates to treat very large respiration related markets that are unserved or poorly served. RespireRx is also developing drugs for niche respiratory markets where premium pricing is probable. All of the Company’s current efforts are involved with ...Founded: 1988
https://www.linkedin.com/company/cortex-pharmaceuticals
Cortex Pharmaceuticals 328 followers on LinkedIn.
https://www.marketscreener.com/quote/stock/CORTEX-PHARMACEUTICALS-9274676/company/
CORTEX PHARMACEUTICALS : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information OTC Bulletin Board ...
https://www.cell.com/cell-chemical-biology/fulltext/S1074-5521(03)00250-3
Nov 01, 2003 · Cortex Pharmaceuticals, Inc. in Irvine, California, engages in the discovery, development, and commercialization of novel compounds that enhance memory and cognition and thus impact a range of disorders. Since 1993, Cortex has been arduously refining their patented AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor modulator ...
https://finance.yahoo.com/news/cortex-pharmaceuticals-inc-announces-name-130000915.html
Dec 17, 2015 · Cortex Pharmaceuticals, Inc. is providing investors and shareholders with a 2015 year-end update and a summary overview of the Company's clinical trial plans for 2016.
https://www.globenewswire.com/news-release/2015/12/17/1087260/0/en/Cortex-Pharmaceuticals-Inc-Announces-Name-Change-and-Symbol-Change.html
Dec 17, 2015 · GLEN ROCK, NJ--(Marketwired - Dec 17, 2015) - Cortex Pharmaceuticals, Inc. (OTC: CORX) (the "Company") is providing investors and shareholders with a 2015 year-end update and a summary overview of ...
https://www.businesswire.com/news/home/20070904005602/en/ROTH-2007-New-York-Conference-Presenter-Profiles
Sep 04, 2007 · Cortex Pharmaceuticals, Inc. is a neuroscience company focused on the R&D of AMPAKINE ®, a pharmacology that represents a new approach to treat psychiatric and neurological disorders. AMPAKINE ...
https://jobsinmalawi.blogspot.com/2014/04/in-country-coordinator-matola-mozambique.html
PATH seeks an In-Country Coordinator to join the MalariaCare partnership in Mozambique. MalariaCare is a global project funded by the United States Agency for International Development under the President’s Malaria Initiative. The partnership aims to achieve universal diagnosis and appropriate case management for malaria by strengthening the ...
https://en.wikipedia.org/wiki/Cortex_Pharmaceuticals
RespireRx Pharmaceuticals Inc. (formerly Cortex Pharmaceuticals, Inc.) (OTCQB: RSPI) is a pharmaceutical company based in Glen Rock, New Jersey specializing in positive allosteric modulators of the AMPA receptor known as Ampakines. History. In February 2005, Cortex received U.S. Food and Drug Administration approval to begin Phase II clinical trials for CX717 for use as a treatment for ...
Have you found Cortex Pharmaceuticals Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.
Related Pages:
|
Recently Added Pages:
|